Stacy E. Croteau, MD, MMS

Stacy E. Croteau, MD, MMS



Instructor in Pediatrics, Harvard Medical School

    Contact: 617-632-3041
  • Fax: 617-730-0641

Medical Services

Specialties

  • Hemophilia
  • Thrombosis

Departments

  • Hematology / Oncology

Programs

  • Blood Disorders Center
To schedule an appointment: Call 617-632-3041 or Request an Appointment

Experience and Education

Education

Medical School

Brown University, 2007

Providence, RI

Residency

Boston Combined Residency Program, Boston Children's Hospital/ Boston Medical Center, 2010

Boston, MA

Fellowship, Pediatric Hematology/ Oncology

Boston Children's Hospital/ Dana-Farber Cancer Institute, 2014

Boston, MA

Certifications

  • Pediatrics

Publications

Publications powered by Harvard Catalyst Profiles
  1. Croteau SE, Gupta D. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma. Semin Cutan Med Surg. 2016 Sep; 35(3):147-52.
  2. Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL. Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. Pediatr Blood Cancer. 2016 Oct; 63(10):1822-8.
  3. Croteau SE, Padula M, Quint K, D'Angelo L, Neufeld EJ. Center-Based Quality Initiative Targets Youth Preparedness for Medical Independence: HEMO-Milestones Tool in a Comprehensive Hemophilia Clinic Setting. Pediatr Blood Cancer. 2016 Mar; 63(3):499-503.
  4. Croteau SE, Neufeld EJ. Author's response: 'Transition considerations for extended half-life factor products'. Haemophilia. 2015 Sep; 21(5):e454-5.
  5. Croteau SE, Neufeld EJ. Transition considerations for extended half-life factor products. Haemophilia. 2015 May; 21(3):285-8.
  6. Croteau SE, Saxena K, Neufeld EJ. Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark? Haemophilia. 2015 Mar; 21(2):190-5.
  7. Croteau SE, Kozakewich HP, Perez-Atayde AR, Fishman SJ, Alomari AI, Chaudry G, Mulliken JB, Trenor CC. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr. 2014 Feb; 164(2):383-8.
  8. Croteau SE, Luo HY, Lehmann LE, Chui DH, Neufeld EJ. Novel dominant ß-thalassemia: Hb Boston-Kuwait [codon 139/140(+T)]. Pediatr Blood Cancer. 2013 Oct; 60(10):E131-4.
  9. Croteau SE, Henderson ER, Billett AL, Gebhardt MC, Voss SD. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2013 Oct; 60(10):E113-5.
  10. Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor CC. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013 Jan; 162(1):142-7.
  11. Show all
  12. Hartmann J, Croteau SE. 2017 Clinical trials update: Innovations in hemophilia therapy. Am J Hematol. 2016 Dec; 91(12):1252-1260.
To schedule an appointment: Call 617-632-3041 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close